168 related articles for article (PubMed ID: 19550240)
1. "The best-laid plans ... often go awry ...".
Urbanic JJ; Lally B; Blackstock AW
J Thorac Oncol; 2009 Jul; 4(7):783-4. PubMed ID: 19550240
[No Abstract] [Full Text] [Related]
2. High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin.
Arrieta O; Gallardo-Rincón D; Villarreal-Garza C; Michel RM; Astorga-Ramos AM; Martínez-Barrera L; de la Garza J
J Thorac Oncol; 2009 Jul; 4(7):845-52. PubMed ID: 19487963
[TBL] [Abstract][Full Text] [Related]
3. Combination chemoradiotherapy with gemcitabine: potential applications.
Choy H
Oncology (Williston Park); 2000 Jul; 14(7 Suppl 4):20-5. PubMed ID: 10960941
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine and radiation therapy for non-small cell lung cancer.
Vokes EE; Gregor A; Turrisi AT
Semin Oncol; 1998 Aug; 25(4 Suppl 9):66-9. PubMed ID: 9728588
[TBL] [Abstract][Full Text] [Related]
5. Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.
Trodella L; D'Angelillo RM; Ramella S; Cellini F; Ciresa M; Cesario A; Granone P
Ann Oncol; 2006 May; 17 Suppl 5():v52-4. PubMed ID: 16807463
[TBL] [Abstract][Full Text] [Related]
6. [Two cases of radiation myositis probably induced by recall phenomenon].
Miura G; Matsumoto T; Tanaka N; Emoto T; Kawamura T; Matsunaga N
Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Sep; 63(8):420-2. PubMed ID: 14587415
[TBL] [Abstract][Full Text] [Related]
7. [Gemcitabine and radiotherapy in non-small cell lung cancer: dolce vita at last!].
Girard N; Mornex F
Bull Cancer; 2007; 94 Spec No Actualites():S127-33. PubMed ID: 17845982
[TBL] [Abstract][Full Text] [Related]
8. [Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy].
Rixe O
Rev Mal Respir; 2001 Sep; 18(4 Pt 1):365-6. PubMed ID: 11547240
[No Abstract] [Full Text] [Related]
9. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
Zwitter M; Kovac V; Smrdel U; Strojan P
J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
[TBL] [Abstract][Full Text] [Related]
10. [Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice].
Azria D; Coelho M; Larbouret C; Lemanski C; Serre A; Ychou M; Pèlegrin A; Dubois JB; Culine S
Cancer Radiother; 2004 Nov; 8 Suppl 1():S106-13. PubMed ID: 15679255
[TBL] [Abstract][Full Text] [Related]
11. [Gemcitabine and radiotherapy for the future].
Girard N; Mornex F
Cancer Radiother; 2007 Jun; 11(4):167-8. PubMed ID: 17601763
[No Abstract] [Full Text] [Related]
12. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells.
Zhang M; Boyer M; Rivory L; Hong A; Clarke S; Stevens G; Fife K
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):353-60. PubMed ID: 14751503
[TBL] [Abstract][Full Text] [Related]
14. [Combined gemcitabine and radiotherapy].
Mornex F
Bull Cancer; 2002 Aug; 89 Spec No():S127-33. PubMed ID: 12449044
[TBL] [Abstract][Full Text] [Related]
15. [Radiochemotherapy in non-small-cell lung cancer].
Swartman B
Med Klin Intensivmed Notfmed; 2011 Nov; 106(3):212-7. PubMed ID: 22068757
[No Abstract] [Full Text] [Related]
16. [Paclitaxel and simultaneous radiotherapy in stage-III non-small-cell bronchial carcinoma].
Wolf M; Faoro C; Görg C; Merte H; Pfab R; Diergarten K; Havemann K
Strahlenther Onkol; 1996 May; 172 Suppl 1():5-8. PubMed ID: 8633270
[No Abstract] [Full Text] [Related]
17. [Efficacy of gemcitabine with concurrent radiotherapy on stage III,inoperable non-small cell lung cancer].
Li GZ; Zhang SH; Zhang Z; Wang RL
Ai Zheng; 2007 Dec; 26(12):1377-80. PubMed ID: 18076806
[TBL] [Abstract][Full Text] [Related]
18. O02.03 Value of adding erlotinib to thoracic radiation therapy with chemotherapy for stage III non-small cell lung cancer: a prospective phase II study.
Clin Adv Hematol Oncol; 2014 Jan; 12(1 Suppl 1):6. PubMed ID: 24852396
[No Abstract] [Full Text] [Related]
19. Five-year results of a phase II trial of hyperfractionated radiotherapy and concurrent daily cisplatin chemotherapy for stage III non-small-cell lung cancer.
Keene KS; Harman EM; Knauf DG; McCarley D; Zlotecki RA
Am J Clin Oncol; 2005 Jun; 28(3):217-22. PubMed ID: 15923791
[TBL] [Abstract][Full Text] [Related]
20. NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.
Wurstbauer K; Deutschmann H; Kopp P; Kranzinger M; Merz F; Nairz O; Studnicka M; Sedlmayer F
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():38-40. PubMed ID: 18167008
[No Abstract] [Full Text] [Related]
[Next] [New Search]
